Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xinxia Zhu

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Translational Oncology|October 1, 2024
GDF15 and LCN2 for early detection and prognosis of pancreatic cancerXinxia Zhu, Brennan Olson, Dove Keith, et al.
Nature Communications|April 7, 2021
Lipocalin 2 mediates appetite suppression during pancreatic cancer cachexiaBrennan Olson, Xinxia Zhu, Mason A Norgard, et al.
Brain, Behavior, and Immunity|November 6, 2024
Tumor-derived cyclooxygenase-2 fuels hypothalamic inflammationXiaolin Li, Xinxia Zhu, Parham Diba, et al.
Cellular and Molecular Gastroenterology and Hepatology|March 18, 2026
Interleukin 6 drives durable T cell-mediated immunity to pancreatic cancerPaige C Arneson-Wissink, Alexandra Q Bartlett, Heike Mendez, et al.
Nature Communications|November 16, 2019
Publisher Correction: The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancerKatherine A Michaelis, Mason A Norgard, Xinxia Zhu, et al.
Theranostics|December 18, 2018
Increasing lean muscle mass in mice via nanoparticle-mediated hepatic delivery of follistatin mRNACanan Schumann, Duc X Nguyen, Mason Norgard, et al.
Nature Communications|October 17, 2019
The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancerKatherine A Michaelis, Mason A Norgard, Xinxia Zhu, et al.
Small (Weinheim an Der Bergstrasse, Germany)|September 13, 2022
Nanoparticle-Based Follistatin Messenger RNA Therapy for Reprogramming Metastatic Ovarian Cancer and Ameliorating Cancer-Associated CachexiaTetiana Korzun, Abraham S Moses, Jeonghwan Kim, et al.
ACS Nano|November 21, 2024
Targeting Metastasis in Head and Neck Squamous Cell Carcinoma Using Follistatin mRNA Lipid NanoparticlesVladislav Grigoriev, Tetiana Korzun, Abraham S Moses, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Translational Oncology|October 1, 2024
GDF15 and LCN2 for early detection and prognosis of pancreatic cancerXinxia Zhu, Brennan Olson, Dove Keith, et al.
Nature Communications|April 7, 2021
Lipocalin 2 mediates appetite suppression during pancreatic cancer cachexiaBrennan Olson, Xinxia Zhu, Mason A Norgard, et al.
Brain, Behavior, and Immunity|November 6, 2024
Tumor-derived cyclooxygenase-2 fuels hypothalamic inflammationXiaolin Li, Xinxia Zhu, Parham Diba, et al.
Cellular and Molecular Gastroenterology and Hepatology|March 18, 2026
Interleukin 6 drives durable T cell-mediated immunity to pancreatic cancerPaige C Arneson-Wissink, Alexandra Q Bartlett, Heike Mendez, et al.
Nature Communications|November 16, 2019
Publisher Correction: The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancerKatherine A Michaelis, Mason A Norgard, Xinxia Zhu, et al.
Theranostics|December 18, 2018
Increasing lean muscle mass in mice via nanoparticle-mediated hepatic delivery of follistatin mRNACanan Schumann, Duc X Nguyen, Mason Norgard, et al.
Nature Communications|October 17, 2019
The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancerKatherine A Michaelis, Mason A Norgard, Xinxia Zhu, et al.
Small (Weinheim an Der Bergstrasse, Germany)|September 13, 2022
Nanoparticle-Based Follistatin Messenger RNA Therapy for Reprogramming Metastatic Ovarian Cancer and Ameliorating Cancer-Associated CachexiaTetiana Korzun, Abraham S Moses, Jeonghwan Kim, et al.
ACS Nano|November 21, 2024
Targeting Metastasis in Head and Neck Squamous Cell Carcinoma Using Follistatin mRNA Lipid NanoparticlesVladislav Grigoriev, Tetiana Korzun, Abraham S Moses, et al.
Pageof 5